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Introduction  
Pathogenic mitochondrial DNA (mtDNA) mutations are usually present in a heteroplasmic 
form and transmission of such disorders is exclusively through the maternal line. Hence, it is 
important to evaluate whether pre-implantation genetic diagnosis (PGD) is accurate and 
reliable in distinguishing healthy oocytes and embryos from affected ones by measuring 
heteroplasmic load in polar bodies (PB) and blastomeres. In this study, heteroplasmic mice, 
carrying genotypes of NZB and BALB mtDNA, were used as a model to investigate the 
reliability of PGD.  
 
Materials and methods  
From 5 mice containing heteroplasmic mtDNA, 92 samples were analysed. First PBs were 
biopsied from metaphase II (MII) oocytes, which were fertilized by intra-cytoplasmic sperm 
injection (ICSI) to analyse second PB and zygotes. Parts of the fertilized oocytes were further 
cultured to harvest blastomeres from 2-cell, 4-cell and 8-cell embryos. The heteroplasmic load 
was measured by restriction fragment length polymorphism (RFLP) method. Correlation was 
verified between the heteroplasmic load of first PB and ooplasm of MII oocytes; between first 
PB, second PB and zygotes; and between first PB, second PB and individual blastomeres of 
cleavage stage embryos. Inter-blastomere variation within an embryo was also analysed at 
different embryonic stages.  Data were analysed using Wilcoxon’s Signed Rank test to check 
the significant difference. p<0.05 was considered significant. Coefficient of correlation (r) 
was calculated by Pearson’s correlation test.  
 
Results 
Our results showed that there was no significant difference in levels of heteroplasmy between 
ooplasm of a mature oocyte (n=10) and the first PB (n=10) (r=0.92); between first PB (n=10), 
second PB (n=10) and zygotes (n=10) (r=0.907 and 0.922 respectively); between first and 
second PBs (r=0.88); and between first PB (n=7) and blastomeres (n=28) (r=0.968). 
However, there was significant difference in heteroplasmic level between second PB (n=7) 
and their corresponding blastomeres (r=0.70). The difference in heteroplasmic level ranged 
from 0.09 to 15 % between MII oocytes and first PBs; 0.34 to 12.48 % between first and 
second PBs; 0.16 to 8.81 % between zygotes and first PBs; 0.29 to 8.82 % between zygotes 
and second PBs, respectively. The inter-blastomere variation ranged from 0.57 to 7.99 %.  
 
Conclusion 
These data show that first PBs are more reliable than second PBs in diagnosing heteroplasmy 
level in oocytes and embryos in our heteroplasmic mouse model. Moreover, compared to first 
PBs, blastomeres give better predictive values of heteroplasmy level in embryos. Currently, 
there is still controversy about the reliability of using PGD for human mitochondrial 
disorders. Thus, it will be important to confirm our mouse results in human patients. 
  
